Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06832085 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation

Study acronym: CanQuit RCT
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 1500 to 150v3 Show 4 more changesShow less
    • Primary completion date: Aug 2026 to Apr 30, 2027
    • Study completion date: Dec 2026 to Oct 30, 2027
    • Study description expanded, about 38 words
    • Collaborators revised (3)
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Start date changed from estimate of Mar 2025 to Apr 30, 2025
    • Eligibility criteria shortened, about 10 words
    • Secondary endpoints: details revised at 3 of 9 entries
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this vanguard trial is to test whether clients of Sun Life are willing to join in a quit smoking program that offers counselling and tobacco cessation products to all participants over a 12-month period. The study team will track the safety and usage of 3 types of cessation products as well as the effectiveness of a virtual pharmacy (i.e. cessation products delivered to participants directly from a pharmacy). The goal is to recruit a minimum of 150 participants for this Vanguard phase. The purpose of this study is to look at 3 approved smoking cessation products used in combination with counselling and virtual delivery of the smoking cessation products. The goal is to track product usage, safety, and adherence (how much of the products people use and how many counselling sessions they complete). Within the study there will also be an observational group who will not receive study medication but who will receive free virtual coaching and follow-up for smoking cessation and complete study questionnaires.
Trial Details
NCT Number NCT06832085
Lead Sponsor Ottawa Heart Institute Research Corporation
Collaborators: Sun Life Assurance Company of Canada, Vita Aid Professional Therapeutics, Pillway Health Pharmacy
Conditions
(from sponsor)		 Tobacco
Related terms Tobacco Use Cessation
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov